Development of an Algorithm for Cervical High-Grade Squamous Intraepithelial Lesion Based on Breath Print Analysis

被引:1
作者
Dokter, Laura A. [1 ]
a Nijeholt, Jeanine H. [1 ]
Rigterink, Bernadette M. [1 ]
de Lange, Natascha M. [1 ]
de Haan, Harm H. [1 ]
van Eijndhoven, Hugo W. F. [1 ]
Joostens, Mieke [1 ]
Kruse, Arnold-Jan [1 ,2 ,3 ,4 ]
机构
[1] Isala Hosp, Dept Obstet & Gynecol, Zwolle, Netherlands
[2] Maastricht Univ Med Ctr, Dept Obstet & Gynecol, Maastricht, Netherlands
[3] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, GROW, Maastricht, Netherlands
[4] Isala Clin, Dept Obstet & Gynecol, POB 10400, NL-8000 GK Zwolle, Netherlands
关键词
high-grade squamous intraepithelial lesions; algorithm; electronic nose technology; breath analysis; volatile organic compounds; diagnosis; ELECTRONIC-NOSE; LUNG-CANCER; DISCRIMINATION;
D O I
10.1097/LGT.0000000000000707
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectivesThis study was designed to develop an algorithm for the diagnosis of cervical high-grade squamous intraepithelial lesions (HSIL), based on patterns of volatile organic compounds, evaluated using an e-nose.MethodsFor this pilot study, the study population consisted of a group of 25 patients with histologically confirmed HSIL and a group of 26 controls. Controls consisted of women visiting the outpatient department for gynecological complaints unrelated to cancer. Women had a negative high-risk human papillomavirus and/or normal cytology (negative for intraepithelial lesions of malignancy) of their most recent test performed in the context of participation in routine cervical cancer screening. Breath tests were performed and labeled with the correct diagnosis. Machine-learning techniques were used to develop a model for predicting HSIL. Based on the receiver operating characteristics curve, both sensitivity and specificity were calculated.ResultsIndividual classifications of all patients with HSIL and controls, as calculated by the model, showed a sensitivity of 0.88 (95% CI = 0.68-0.97) and specificity of 0.92 (95% CI = 0.73-0.99). The positive predictive value and the negative predictive value were 0.92 (95% CI = 0.72-0.99) and 0.89 (95% CI = 0.70-0.97), respectively. The Cohen kappa coefficient was 0.80.ConclusionsE-nose can detect distinctive patterns of volatile organic compounds between cervical HSIL patients and controls. Validation of the algorithm in further studies is necessary before possible implementation into daily practice.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 23 条
  • [1] Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
    Aitken, Clare A.
    van Agt, Heleen M. E.
    Siebers, Albert G.
    van Kemenade, Folkert J.
    Niesters, Hubert G. M.
    Melchers, Willem J. G.
    Vedder, Judith E. M.
    Schuurman, Rob
    van den Brule, Adriaan J. C.
    van der Linden, Hans C.
    Hinrichs, John W. J.
    Molijn, Anco
    Hoogduin, Klaas J.
    van Hemel, Bettien M.
    de Kok, Inge M. C. M.
    [J]. BMC MEDICINE, 2019, 17 (01)
  • [2] The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva
    Amann, Anton
    Costello, Ben de Lacy
    Miekisch, Wolfram
    Schubert, Jochen
    Buszewski, Boguslaw
    Pleil, Joachim
    Ratcliffe, Norman
    Risby, Terence
    [J]. JOURNAL OF BREATH RESEARCH, 2014, 8 (03)
  • [3] [Anonymous], 2008, Applied Multiway Data Analysis
  • [4] Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
    Arbyn, Marc
    Smith, Sara B.
    Temin, Sarah
    Sultana, Farhana
    Castle, Philip
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [5] CANCER PREVENTION IN PRIMARY-CARE - SCREENING FOR CERVICAL-CANCER .7.
    AUSTOKER, J
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6949) : 241 - 248
  • [6] Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer
    Bikov, Andras
    Hernadi, Marton
    Korosi, Beata Zita
    Kunos, Laszlo
    Zsamboki, Gabriella
    Sutto, Zoltan
    Tarnoki, Adam Domonkos
    Tarnoki, David Laszlo
    Losonczy, Gyorgy
    Horvath, Ildiko
    [J]. BMC PULMONARY MEDICINE, 2014, 14
  • [7] Methylation markersFAM19A4andmiR124-2as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
    Bonde, Jesper
    Floore, Arno
    Ejegod, Ditte
    Vink, Frederique J.
    Hesselink, Albertus
    van de Ven, Peter M.
    Valencak, Anja Ostrbenk
    Pedersen, Helle
    Doorn, Saskia
    Quint, Wim G.
    Petry, Karl Ulrich
    Poljak, Mario
    Stanczuk, Grazyna
    Cuschieri, Kate
    de Sanjose, Silvia
    Bleeker, Maaike
    Berkhof, Johannes
    Meijer, Chris J. L. M.
    Heideman, Danielle A. M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (02) : 396 - 405
  • [8] An investigation on electronic nose diagnosis of lung cancer
    D'Amico, Arnaldo
    Pennazza, Giorgio
    Santonico, Marco
    Martinelli, Eugenio
    Roscioni, Claudio
    Galluccio, Giovanni
    Paolesse, Roberto
    Di Natale, Corrado
    [J]. LUNG CANCER, 2010, 68 (02) : 170 - 176
  • [9] An electronic nose in the discrimination of patients with asthma and controls
    Dragonieri, Silvano
    Schot, Robert
    Mertens, Bart J. A.
    Le Cessie, Saskia
    Gauw, Stefanie A.
    Spanevello, Antonio
    Resta, Onofrio
    Willard, Nico P.
    Vink, Teunis J.
    Rabe, Klaus F.
    Bel, Elisabeth H.
    Sterk, Peter J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (04) : 856 - 862
  • [10] An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD
    Dragonieri, Silvano
    Annema, Jouke T.
    Schot, Robert
    van der Schee, Marc P. C.
    Spanevello, Antonio
    Carratu, Pierluigi
    Resta, Onofrio
    Rabe, Klaus F.
    Sterk, Peter J.
    [J]. LUNG CANCER, 2009, 64 (02) : 166 - 170